ACCELERON PHARMA INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 69 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-05: Reporting owner Zakrzewski Joseph S; Form 4; Security Option to purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-05: Reporting owner POPS RICHARD F; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-05: Reporting owner Maniatis Tom; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-05: Reporting owner MCGUIRE TERRANCE; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-05 | Zakrzewski Joseph S Director | 4 | Option to purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | POPS RICHARD F Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Maniatis Tom Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | MCGUIRE TERRANCE Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | KANIA EDWIN M JR Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | George Jean Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Quisel John D Officer (VP General Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,000 29,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Ertel Steven D Officer (SVP & Chief Business Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,000 29,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,000 29,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,000 29,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,000 29,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-12-05 | EVNIN ANTHONY B Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.11 exercise price | 2013-12-09 | |
| 2013-09-18 holding as of filing | Steininger Robert J II Officer (SVP, Manufacturing) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Steininger Robert J II Officer (SVP, Manufacturing) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Steininger Robert J II Officer (SVP, Manufacturing) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Steininger Robert J II Officer (SVP, Manufacturing) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.12 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Sherman Matthew L Officer (SVP & Chief Medical Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.48 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | POPS RICHARD F Director | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | POPS RICHARD F Director | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.12 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Maniatis Tom Director | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Maniatis Tom Director | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.12 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.92 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.40 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Knopf John L Director, Officer (CEO and President) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.40 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Zakrzewski Joseph S Director | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.12 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.92 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.92 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Ertel Steven D Officer (SVP & Chief Business Officer) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.40 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.12 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.28 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.08 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $1.80 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Quisel John D Officer (VP General Counsel & Secretary) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $0.92 exercise price | 2013-09-18 |